These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37199754)

  • 1. Longitudinal change in neurocognitive functioning in children and adolescents at clinical high risk for psychosis: a systematic review.
    Pedruzo B; Aymerich C; Pacho M; Herrero J; Laborda M; Bordenave M; Giuliano AJ; McCutcheon RA; Gutiérrez-Rojas L; McGuire P; Stone WS; Fusar-Poli P; González-Torres MÁ; Catalan A
    Eur Child Adolesc Psychiatry; 2023 May; ():. PubMed ID: 37199754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis.
    Catalan A; Salazar de Pablo G; Aymerich C; Damiani S; Sordi V; Radua J; Oliver D; McGuire P; Giuliano AJ; Stone WS; Fusar-Poli P
    JAMA Psychiatry; 2021 Jun; 78(8):859-67. PubMed ID: 34132736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis.
    Catalan A; Radua J; McCutcheon R; Aymerich C; Pedruzo B; González-Torres MÁ; Baldwin H; Stone WS; Giuliano AJ; McGuire P; Fusar-Poli P
    Transl Psychiatry; 2022 May; 12(1):198. PubMed ID: 35551176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognition and functioning in adolescents at clinical high risk for psychosis.
    Mensi MM; Orlandi M; Casini E; Catalan A; de Pablo GS; Fusar-Poli P; Borgatti R
    Child Adolesc Psychiatry Ment Health; 2023 Feb; 17(1):22. PubMed ID: 36755293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive Assessments Are More Important Among Adolescents Than Adults for Predicting Psychosis in Clinical High Risk.
    Zhang T; Cui H; Wei Y; Tang X; Xu L; Hu Y; Tang Y; Chen T; Li C; Wang J
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jan; 7(1):56-65. PubMed ID: 34274517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.
    Catalan A; Salazar de Pablo G; Vaquerizo Serrano J; Mosillo P; Baldwin H; Fernández-Rivas A; Moreno C; Arango C; Correll CU; Bonoldi I; Fusar-Poli P
    J Child Psychol Psychiatry; 2021 May; 62(5):657-673. PubMed ID: 32924144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    Hauser M; Zhang JP; Sheridan EM; Burdick KE; Mogil R; Kane JM; Auther A; Carrión RE; Cornblatt BA; Correll CU
    J Clin Psychiatry; 2017 Jan; 78(1):e28-e40. PubMed ID: 28129494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of tobacco smoking in people at clinical high-risk for psychosis: Systematic review and meta-analysis.
    De Micheli A; Provenzani U; Solmi M; Van Pabst AVL; Youssef E; McGuire P; Fusar-Poli P
    Schizophr Res; 2023 Apr; 254():109-115. PubMed ID: 36827942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.
    Carrión RE; Walder DJ; Auther AM; McLaughlin D; Zyla HO; Adelsheim S; Calkins R; Carter CS; McFarland B; Melton R; Niendam T; Ragland JD; Sale TG; Taylor SF; McFarlane WR; Cornblatt BA
    J Psychiatr Res; 2018 Jan; 96():231-238. PubMed ID: 29121595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis.
    Salazar de Pablo G; Catalan A; Vaquerizo Serrano J; Pedruzo B; Alameda L; Sandroni V; Armendariz A; Rodriguez V; Arango C; Moreno C; Downs J; Abbott C; Shin JI; Solmi M; Fusar-Poli P; Correll CU
    Br J Psychiatry; 2023 Jul; 223(1):282-294. PubMed ID: 37194556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
    Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
    JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis.
    Hedges EP; See C; Si S; McGuire P; Dickson H; Kempton MJ
    Psychol Med; 2022 Aug; 52(11):2009-2016. PubMed ID: 35821623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Changes in Cortical Surface Area Associated With Transition to Psychosis in Adolescents at Clinical High Risk for the Disease.
    Fortea A; van Eijndhoven P; Ilzarbe D; Batalla A; Calvet-Mirabent A; de la Serna E; Puig O; Castro-Fornieles J; Dolz M; Tor J; Parrilla S; Via E; Stephan-Otto C; Baeza I; Sugranyes G
    J Am Acad Child Adolesc Psychiatry; 2023 May; 62(5):593-600. PubMed ID: 36638884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    JAMA Psychiatry; 2018 Sep; 75(9):960-968. PubMed ID: 29971330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive and neuroanatomical maturation in the clinical high-risk states for psychosis: A pattern recognition study.
    Kambeitz-Ilankovic L; Haas SS; Meisenzahl E; Dwyer DB; Weiske J; Peters H; Möller HJ; Falkai P; Koutsouleris N
    Neuroimage Clin; 2019; 21():101624. PubMed ID: 30528960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive subtypes in youth at clinical high risk for psychosis.
    Yassin W; Green J; Keshavan M; Del Re EC; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; Perkins DO; Walker EF; Woods SW; Stone WS
    medRxiv; 2024 Aug; ():. PubMed ID: 39211862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
    Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
    JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.